Golden Green, Inc. Moderna, Inc. Transaction History

Golden Green, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 21, 2022	SELL	$225.82 - $368.51 $5.81 Million - $9.48 Million	-25,722 Closed	0 $0
Q3 2021 Oct 08, 2021	SELL	$221.9 - $484.47 $850,764 - $1.86 Million	-3,834 Reduced 12.97%	25,722 $9.9 Million
Q2 2021 Jul 14, 2021	SELL	$129.91 - $234.98 $169,792 - $307,118	-1,307 Reduced 4.23%	29,556 $6.95 Million
Q1 2021 Apr 13, 2021	SELL	$109.18 - $185.98 $246,310 - $419,570	-2,256 Reduced 6.81%	30,863 $4.04 Million
Q4 2020 Jan 25, 2021	BUY	$65.74 - $169.86 $2.18 Million - $5.63 Million	33,119 New	33,119 $3.46 Million

953

240M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Golden Green, Inc., based on Form 13F filings with the SEC.

Stay updated on Golden Green, Inc. with notifications on news.